39.9 F
New York
Wednesday, November 30, 2022

Date:

Share:

Pharmaspectra Group Limited Partners with IBM Watson Health to Help Life Sciences Companies with Stakeholder Management

Related Articles

Vesalio Appoints VP of U.S. Sales and Announces Recent Publication on NeVa Showing Impressive First Pass Rates

Nashville, TN, November 29, 2022 --(PR.com)-- Vesalio is pleased to welcome Bob Bushok as Vice President of U.S. Sales overseeing commercial strategy and execution for...

Principled Technologies Releases Two Studies Comparing Time and Effort for Server Management Tasks with Dell OpenManage Enterprise vs. a Manual Approach

Durham, NC, November 29, 2022 --(PR.com)-- Some of the routine tasks that administrators must handle include monitoring and capping power consumption and applying firmware updates...

MPAI Calls for New Members to Support Its Standard Developments Plans

Geneva, Switzerland, November 25, 2022 --(PR.com)-- The international, non-profit, unaffiliated Moving Picture, Audio and Data Coding by Artificial Intelligence (MPAI) standards developing organisation has concluded...

London, United Kingdom, 23rd September 2020Pharmaspectra, the world’s largest collection of medical science, today announced it has entered into a partnership with IBM Watson Health.

Through the partnership agreement, IBM Watson Health is withdrawing IBM Stakeholder Manager® from its portfolio and offering a transition path for its clients to Pharmaspectra’s product, LINK, the global leader in key opinion leader (KOL) management solutions.

Pharmaspectra logo

Pharmaspectra’s LINK solution combines the world’s leading scientific database, with superior analytics, connecting clients with the right scientific experts, to achieve scientific leadership.

Pharmaspectra Group Limited CEO, Jez Moulding stated, “I am delighted to enter this partnership with IBM as it enables us to further grow and develop our LINK KOL management solution. We look forward to the opportunity to work with IBM’s current clients and to…

Read more…

Popular Articles